Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lack of TNFalpha mRNA expression in cervical cancer is not associated with loss of heterozygosity at 6p21.3, inactivating mutations or promoter methylation.

Molecular immunology - 1 Jan 2008

Kloth Judith N, Gorter Arko, ter Haar Natalja, Corver Willem E, Jordanova Ekaterina S, Kenter Gemma G, Fleuren Gert Jan

Abstract excerpt

Infection with oncogenic human papillomavirus (HPV) is considered to be the major etiologic event for cervical cancer. Tumor necrosis factor alpha (TNFalpha), a proinflammatory cytokine, may be involved in orchestrating an antitumor immune response against human papillomavirus expressing cervical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomes, Human, Pair 6
Share to CpG Islands
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Loss of Heterozygosity

Share to Microsatellite Repeats

Share to Tumor Necrosis Factor-alpha

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 17560652
DOI: 10.1016/j.molimm.2007.04.028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17560652-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lack of TNFalpha mRNA expression in cervical cancer is not associated with loss of heterozygosity at 6p21.3, inactivating mutations or promoter methylation.PMID 17560652Read ↗

TNFalpha polymorphism frequencies in HPV-associated cervical dysplasia.Semantic proximity Read ↗

TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer.Semantic proximity Read ↗

TNF-alpha rs1800629 polymorphism is not associated with HPV infection or cervical cancer in the Chinese population.Semantic proximity Read ↗

Host genetic polymorphism analysis in cervical cancer.Semantic proximity Read ↗

Multiple mechanisms underlie HLA dysregulation in cervical cancer.Semantic proximity Read ↗

Association of a variant in the tumor necrosis factor alpha gene with risk of cervical cancer.Semantic proximity Read ↗

Analysis of TNFα promoter SNPs and the risk of cervical cancer in urban populations of Posadas (Misiones, Argentina).Semantic proximity Read ↗

Association of tumor necrosis factor a-2 and a-8 microsatellite alleles with human papillomavirus and squamous intraepithelial lesions among women in Brazil.Semantic proximity Read ↗

Chromosome 6p21.2, 18q21.2 and human papilloma virus (HPV) DNA can predict prognosis of cervical cancer after radiotherapy.Semantic proximity Read ↗

HPV-associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA.Semantic proximity Read ↗

Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.Semantic proximity Read ↗

Lack of Associations between TNF-αPolymorphisms and Cervical Cancer in Thai women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.